Onderneming Aequus Pharmaceuticals Inc Toronto S.E.
Aandelen
CA0076361033
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical Drugs
100,0
%
| 0 | 17,6 % | 0 | 100,0 % | +5,01% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 1 | 100,0 % | 0 | 100,0 % | -81,53% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Anne Stevens
FOU | Founder | - | 01-01-13 |
Douglas Janzen
CEO | Chief Executive Officer | 56 | 03-01-13 |
Ann Fehr
DFI | Director of Finance/CFO | 55 | 22-07-16 |
Andre Mbeng
AUD | Comptroller/Controller/Auditor | 45 | 01-11-20 |
Grant Larsen
PRN | Corporate Officer/Principal | - | 17-08-20 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Douglas Janzen
CEO | Chief Executive Officer | 56 | 03-01-13 |
Marc Lustig
BRD | Director/Board Member | 51 | 15-02-21 |
Director/Board Member | 54 | 18-12-14 | |
Anne Stevens
FOU | Founder | - | 01-01-13 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 132 634 431 | 113 163 965 ( 85,32 %) | 0 | 85,32 % |
Bedrijfsgegevens
Aequus Pharmaceuticals, Inc.
200 Granville Street Suite 2820
V6C 1S4, Vancouver
+604 336 7906
http://www.aequuspharma.caSector
Verkoop per activiteit
Vaira. 1 jan. | Kapi. | |
---|---|---|
+31,37% | 588 mld. | |
-2,76% | 364 mld. | |
+20,59% | 326 mld. | |
+5,64% | 285 mld. | |
+14,83% | 239 mld. | |
+9,93% | 210 mld. | |
-6,95% | 200 mld. | |
+11,02% | 167 mld. | |
+0,09% | 161 mld. |